Randomized study of intensive MOOP-ABVD with or without low-dose total- nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: A Pediatric Oncology Group Study

Journal of Clinical Oncology

Volumn 15, Issue 8, 1997, Pages 2769-2779

  Weiner, Michael A ^a   Leventhalt, Brigid ^a   Brecher, Martin L ^a   Marcus, Robert B ^a   Cantor, Alan ^a   Gieser, Peter W ^a   Ternberg, Jessie L ^a   Behm, Fred G ^a   Wharam Jr , Moody D ^a   Chauvenet, Allen R ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD TOXICITY; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; LIVER TOXICITY; LOW ENERGY RADIATION; LYMPH NODE BIOPSY; LYMPH NODE IRRADIATION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NEUROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION;

EID: 0030818923     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.8.2769     Document Type: Article

References (47)

1. Hunger SP, Link MP, Donaldson SS: ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: The Stanford experience. J Clin Oncol 12:2160-2166, 1994
2. Oberlin O, Levenger G, Pacquement H, et al: Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: The experience of the French Society of Pediatric Oncology. J Clin Oncol 10:1602-1608, 1992
3. Schellong G, Hornig I, Schwarze EW, et al: Risk factor adapted treatment of Hodgkin's lymphoma in childhood: Strategies and results of three consecutive multicenter studies in the Federal Republic of Germany. Recent Results Cancer Res 117:205-213, 1989
4. Hudson MM, Greenwald C, Thompson E, et al: Efficacy and toxicity of multiagent chemotherapy and low-dose involved field radiotherapy in children and adolescents with Hodgkin's disease. J Clin Oncol 11:100-108, 1993
5. Fryer CJ, Hutchinson RJ, Krailo M, et al: Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: A report from the Children's Cancer Study Group. J Clin Oncol 8:1971-1980, 1990
6. Bramswig JH, Hornig-Franz I, Riepenhausen M, et al: The challenge of pediatric Hodgkin's disease: Where is the balance between cure and long-term toxicity? A report of the West German multicenter studies, DAL-HD-78, DAL-HD-82, and DAL-HD-85. Leuk Lymphoma 3:183-193, 1990
7. Khan SP, Gilchrist GS, Arndt AS, et al: Vancouver hybrid: Preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence. Mayo Clin Proc 69:949-954, 1994
8. Weiner MA, Leventhal BG, Marcus R, et al: Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: A Pediatric Oncology Group study. J Clin Oncol 9:1591-1598, 1991
9. Carbone PP, Kaplan HS, Musshoff K, et al: Report of the Committee on Hodgkin's Disease Classification. Cancer Res 31:1860-1861, 1971
10. Desser RK, Golomb HM, Ultmann JE, et al: Prognostic classification of Hodgkin's disease in pathologic stage III, based on anatomic considerations. Blood 49:883-893, 1977
11. Lukes RJ, Butler JJ: The pathology and nomenclature of Hodgkin's disease. Cancer Res 26:1063-1081, 1966
12. DeVita VT Jr, Serpick AA, Carbone PP: Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 73:881-895, 1970
13. DeVita VT Jr, Simon RM, Hubbard SM, et al: Curability of advanced Hodgkin's disease with chemotherapy: Long-term follow-up of MOPP treated patients at the National Cancer Institute. Ann Intern Med 92:587-595, 1980
14. Bonadonna G, Zucali R, Monfardini s, et al: Combination chemotherapy of Hodgkin's disease with Adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer 36:252-259, 1975
15. Bonadonna G, Valagussa P, Santoro A: Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. Ann Intern Med 104:739-746, 1986
16. Hoppe RT: Radiation therapy in the management of Hodgkin's disease. Semin Oncol 17:704-715, 1990
17. Doria R, Holford T, Farber L, et al: Second solid malignancies after combined modality therapy for Hodgkin's disease. J Clin Oncol 13:2016-2022, 1995
18. Lange B, Littman P: Management of Hodgkin's disease in children and adolescents. Cancer 51:1371-1377, 1983
19. Jenkin D, Chan H, Freedman M, et al: Hodgkin's disease in children: Treatment results with MOPP and low dose extended-field irradiation. Cancer Treat Rep 66:949-959, 1982
20. Mauch PM, Weinstein H, Botnick L, et al: An evaluation of long-term survival and treatment complications in children with Hodgkin's disease. Cancer 51:925-932, 1983
21. Donaldson SS, Kaplan HS: Complications of treatment of Hodgkin's disease in children. Cancer Treat Rep 66:977-989, 1982
22. Probert JC, Parker BR, Kaplan HS: Growth retardation in children after megavoitage irradiation of the spine. Cancer 32:634-639, 1973
23. Weiner MA, Landmann RG, Deparedes L, et al: Vesiculated erythrocytes as a determination of splenic reticuloendothelial function in pediatric patients with Hodgkin's disease. J Pediatr Hematol Oncol 17:338-341, 1995
24. Fabian CJ, Mansfield CM, Dahlberg S, et al: Low-dose involved field radiation after chemotherapy in advanced Hodgkin's disease. Ann Intern Med 120:903-912, 1994
25. Prosnitz LR, Farber LR, Kapp DS, et al: Combined modality therapy for Hodgkin's disease: 15 year follow-up data. J Clin Oncol 6:603-612, 1988
26. Steinherz P, Gaynon P, Breneman J, et al: Early marrow response is a powerful predictor of outcome in acute lymphoblastic leukemia with unfavorable presenting features. Proc Am Assoc Cancer Res 35:240, 1994 (abstr)
27. Gajjar A, Ribiero R, Hancock ML, et al: Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood lymphoblastic leukemia. Blood 86:1292-1295, 1995
28. Ekert H, Waters KD, Smith PJ, et al: Treatment with MOPP or ChIVPP chemotherapy only for all stages of childhood Hodgkin's disease. J Clin Oncol 6:1845-1850, 1988
29. Behrendt H, Van Bubbingen BNFM, Van Leeuwen EF: Treatment of Hodgkin's disease in children with or without radiotherapy. Cancer 59:1870-1873, 1987
30. Cooper DL, DeVita VT Jr: Hodgkin's disease: Current therapy and controversies. Advances Oncol 10:17-24, 1994
31. Click J, Tsiatis A, Chen M, et al: A randomized ECOG trial of alternating MOPP-ABVD vs BCVPP plus radiotherapy for advanced Hodgkin's disease. Proc Am Soc Clin Oncol 7:223, 1988 (abstr)
32. Glick J, Tsiatis A, Chen M, et al: Improved survival with MOPP/ABVD compared to BCVPP +/- radiotherapy for advanced Hodgkin's disease: 6-year ECOG results. Blood 76:351a, 1990 (suppl 1, abstr)
33. Bader SB, Weinstein H, Mauch P, et al: Pediatric stage IV Hodgkin's disease: Long-term survival. Cancer 72:249-255, 1993
34. Canellos GP, Anderson JR, Propert KJ, et al: Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 32:1478-1484, 1992
35. Comis R, Kuppinger M, Ginsberg S, et al: Role of single-breath carbon monoxide diffusing capacity ion monitoring the pulmonary effects of bleomycin in germ cell tumor patients. Cancer Res 39:5076-5080, 1979
36. Bauer KA, Skarin AT, Balikian JP, et al: Pulmonary complications associated with combination chemotherapy programs containing bleomycin. Am J Med 74:557-563, 1983
37. Mefferd JM, Donaldson SS, Link MP: Pediatric Hodgkin's disease: Pulmonary, cardiac, and thyroid function, following combined modality therapy. Int J Radiat Oncol Biol Phys 16:679-685, 1989
38. Hancock SL, Donaldson SS, Hoppe RT: Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 11:1208-1215, 1993
39. DeWolf D, Suys B, Matthys D, et al: Stress echocardiography in the evaluation of late cardiac toxicity after moderate dose of anthracycline therapy in childhood. Int J Pediatr Hematol Oncol 1:399-404, 1994
40. Bramswig JH, Heimes U, Heiermann E, et al: The effects of different cumulative doses of chemotherapy on testicular function. Cancer 65:1298-1302, 1990
41. Myers S, Schilsky R: Prospects for fertility after cancer chemotherapy. Semin Oncol 19:597-604, 1992
42. Waxman J, Terry Y, Wrigley PFM, et al: Gonadal function in Hodgkin's disease: Long-term follow-up off chemotherapy. Br Med J 285:1612-1613, 1982
43. Byrne J, Fears TR, Gail MH, et al: Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 166:788-793, 1992
44. Sy Ortin TT, Shostak CA, Donaldson SS: Gonadal status and reproductive function following treatment for Hodgkin's disease in Childhood: The Stanford experience. Int J Radiat Oncol Biol Phys 19:873-880, 1990
45. Kaldor JM, Day NE, Clarke A, et al: Leukemia following Hodgkin's disease. N Engl J Med 322:7-13, 1990
46. Boivin JF, Hutchison GB, Zauber AG, et al: Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 87:732-741, 1995
47. Beaty O, Hudson MM, Greenwald C, et al: Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 13:603-609, 1995